Arun Kumar

Employment

• Coalition for Epidemic Preparedness Innovations Scientist
  2018 - Present
• Health Sciences North Research Institute Postdoctoral Scientist
  2016 - 2017
• GlaxoSmithKline Vaccines Investigator I
  2015 - 2016
• GlaxoSmithKline Vaccines Marie-Curie Scientist
  2014 - 2015

Education

• Haartman Institute, University of Helsinki PhD
  2008 - 2014

Projects & Funding

Projects & funding information is unavailable.

Publications (22)

• Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need
  npj Vaccines 2023 DOI: 10.1038/s41541-023-00722-x
  +Save
• Status Report on COVID-19 Vaccines Development
  Current Infectious Disease Reports 2021 DOI: 10.1007/s11908-021-00752-3
  +Save
• Considerations for bioanalytical characterization and batch release of COVID-19 vaccines
  npj Vaccines 2021 DOI: 10.1038/s41541-021-00317-4
  +Save
• The COVID-19 vaccine development landscape.
  Nature reviews. Drug discovery 2020 DOI: 10.1038/d41573-020-00073-5
  +Save
• Developing vaccines against epidemic-prone emerging infectious diseases.
  Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2020 DOI: 10.1007/s00103-019-03061-2
  +Save
• Novel Platforms for the Development of a Universal Influenza Vaccine.
  Frontiers in immunology 2018 DOI: 10.3389/fimmu.2018.00600
  +Save
• Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison.
  Human vaccines & immunotherapeutics 2017 DOI: 10.1080/21645515.2017.1337615
  +Save
• Epidemiology of two human protoparvoviruses, bufavirus and tusavirus.
  Scientific reports 2016 DOI: 10.1038/srep39267
  +Save
• Microsphere-based antibody assays for human parvovirus B19V, CMV and T. gondii.
  BMC infectious diseases 2016 DOI: 10.1186/s12879-015-1194-3
  +Save
• B Cells and Functional Antibody Responses to Combat Influenza.
  Frontiers in immunology 2015 DOI: 10.3389/fimmu.2015.00336
  +Save